A SBIR Phase II contract was awarded to Dynavax Technologies in February, 2016 for $1,012,267.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Dynavax Technologies for $1,811,030.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Dynavax Technologies for $599,016.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Dynavax Technologies for $595,550.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Dynavax Technologies for $720,339.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Dynavax Technologies for $207,278.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Dynavax Technologies for $223,390.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Dynavax Technologies for $595,825.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Dynavax Technologies for $404,918.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Dynavax Technologies for $119,349.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Dynavax Technologies for $100,000.0 USD from the U.S. Department of Health & Human Services.